CoChat

Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders

Vanaudenaerde, Bart M., Verleden, Stijn E., Vos, Robin, Vleeschauwer, Stéphanie I. De, Willems-Widyastuti, Anna, Geenens, Rachel, Raemdonck, Dirk E. Van, Dupont, Lieven J., Verbeken, Erik K., Meyts, Isabelle · 2011 · American Journal of Respiratory and Critical Care Medicine
Cited by 99

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

During T-cell receptor activation in a particular cytokine environment, naive CD4+ T cells may differentiate into lineages defined by their pattern of cytokine production and transcription factors: T helper type 1 (Th1), Th2, Th17, and Th22 cells; follicular helper T cells; and inducible regulatory T cells. Th17 cells have been recognized as a distinct lineage of Th cells, and associations between IL-17 and human disease have been known somewhat longer. It would be an oversimplification to restrict IL-17 to Th17 cells. Indeed, IL-17 is also expressed by other cells including IL-17-producing γδ T (γδ T-17) cells, natural killer T-17 cells, and IL-17-producing lymphoid tissue-induced cells. IL-17 was cloned in 1995 as a cytokine expressed by T cells, exerting inflammatory effects on epithelial, endothelial, and fibroblast cells. IL-17 is a solid link between innate and adaptive immunity and can exert both beneficial and deleterious effects. The discovery of IL-17 T cells has provided exciting new insights into host defense, immunoregulation, and autoimmunity. Unquestionably, data from mouse models have contributed enormously to our insight into immunological mechanisms. However, because of numerous differences between murine and human immunology, data obtained in mice are not simply interchangeable. We review IL-17 T cells exclusively in the human situation and more specifically their potential role in respiratory diseases. The advances in our understanding of IL-17 regulation offer opportunities to dissect the human IL-17 system and to reflect on the clinical presentation of lung diseases. More importantly, the IL-17 system allows us to speculate on new therapeutic opportunities. Some results have been previously reported in an abstract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201007-1196pp

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 99

Metadata

Authors
Vanaudenaerde, B. M., Verleden, S. E., Vos, R., Vleeschauwer, S. I. D., Willems-Widyastuti, A., Geenens, R., Raemdonck, D. E. V., Dupont, L. J., Verbeken, E. K., & Meyts, I.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2011-04-15
Volume
183
Issue
8
Pages
977-986
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2002776653
Cited by
99
References
9
FWCI
3.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders. https://app.cochat.ai/papers/10.1164/rccm.201007-1196pp
The paper
Vanaudenaerde, B. M., Verleden, S. E., Vos, R., Vleeschauwer, S. I. D., Willems-Widyastuti, A., Geenens, R., Raemdonck, D. E. V., Dupont, L. J., Verbeken, E. K., & Meyts, I. (2011). Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201007-1196pp

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.